|
|
 |
| Product Name |
Composition |
Therapeutic Use |
Quality Standard |
| Omeprazole Pellets |
7.5%, 8.5%, 10% |
Antiulcerative |
IP/USP/BP |
| Lansoprazole Pellets |
8.5%, 10%, 11.5% |
Antiulcerative |
IHS/USP/EP |
| Pantoprazole Pellets |
15%, 20% |
Antiulcerative |
USP/EP |
| Rabeprazole Pellets |
8.5%, 10%, 20% |
Antiulcerative |
IHS/IP |
| Esomeprazole Pellets |
8.5%, 22.5% |
Antiulcerative |
IHS |
| Itopride Pellets |
10% |
Antiulcerative |
IHS |
|
|
| Itraconazole Pellets |
20%, 22%, |
Antifungal |
EP/BP |
|
|
| Duloxetine Pellets |
10%, 17%, 20% |
Antidepressant |
USP |
|
|
| Domperidone Pellets |
10%, 20%, 40% |
Antiemetic |
IHS |
|
|
| Orlistat Pellets |
50% |
Anti Obesity |
IHS/USP |
|
|
| Tamsulosin HCI Pellets |
0.2%, 0.4% |
BPH |
EP |
|
|
| Ketoprofen |
65%, 70% |
Anti Inflammatory |
IHS/USP |
|
|
| Any other concentration of pellets can be supplied as per customer’s specifications. |
|
None of the products will be supplied to countries in which these could be in conflict with existing patents. However, the final responsibility lies exclusively with the buyer.
|
| Copyright © 2005 Nifty Labs - All rights reserved. |
|
|
